David Gaist

Medicin og biovidenskab

1. Denmark 100%
2. Cerebral Hemorrhage 95%
3. Stroke 76%
4. Case-Control Studies 76%
5. Confidence Intervals 61%
6. Twins 59%
7. Hydroxymethylglutaryl-CoA Reductase Inhibitors 48%
8. Odds Ratio 45%
9. Registries 44%
10. Population 37%
11. Subarachnoid Hemorrhage 37%
12. Polyneuropathies 35%
13. Aspirin 31%
14. Aged, 80 and over 28%
15. Migraine Disorders 26%
16. Pharmaceutical Preparations 25%
17. Anticoagulants 25%
18. Subdural Hematoma 25%
19. Glioma 23%
20. Incidence 22%
21. Migraine with Aura 22%
22. Myasthenia Gravis 21%
23. Cohort Studies 20%
24. Transient Ischemic Attack 20%
25. Hydrochlorothiazide 19%
26. Health 19%
27. Neural Conduction 18%
28. Oxaliplatin 17%
29. Platelet Aggregation Inhibitors 16%
30. Peripheral Nerves 16%
31. Skin Neoplasms 16%
32. General Practice 16%
33. Hand Strength 15%
34. Prescriptions 15%
35. Elderly 15%
36. Mortality 14%
37. Nerve Fibers 14%
38. Twin Studies 13%
39. Drug Utilization 13%
40. Azathioprine 13%
41. Population Control 12%
42. International Normalized Ratio 12%
43. Warfarin 12%
44. Serotonin Uptake Inhibitors 12%
45. Headache 12%
46. Skin 12%
47. Logistic Models 12%
48. Hormone Replacement Therapy 11%
49. Dizygotic Twins 11%
50. Anti-Inflammatory Agents 11%